688315.SH
Novogene Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 19.50
+15.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 35.21x
- P/E 2027E
- 31.03x
- P/E 2028E
- 27.33x
- P/S forward
- 3.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- 48.61x
- PEG TTM
- 1.42x
- Price / book
- 3.03x
- Price / sales
- 3.37x
- Price / cash flow
- 30.87x
Enterprise value
- Enterprise value
- CNY 7.3B
- EV / sales
- 3.24x
- EV / EBITDA
- 22.54x
- EV / EBIT
- 38.09x
- Market cap
- CNY 8.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026